Watching Johnson & Johnson? See every signal — funding, hires, M&A, contracts, sentiment.
Book a demoChoose your planFunding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →
Back to SEC FilingsAcquisition/DispositionItem 2.01 · 8-KLOW RiskPositive
Johnson & Johnson
jnj.comFiled: Jul 27, 2026New Brunswick, New JerseyCIK: 0000200406hospital & health care
AI Executive Summary
AI-powered analysis of 8-K filing content
Johnson & Johnson completed a multi-series debt issuance on July 27, 2026, raising capital through notes with maturities ranging from 2028 to 2055 and interest rates from 1.150% to 3.700%. This strategic debt financing enhances liquidity and demonstrates J&J's ability to access favorable long-term borrowing rates.
Key Takeaways
J&J issued multiple note series with maturities spanning 27 years, indicating a long-term capital strategy
Interest rates range from 1.150% to 3.700%, reflecting favorable market conditions and J&J's strong credit profile
2 more takeaways
Related Filings (1)
1 more filing from Johnson & Johnson in the last 90 days
Filing Overview
Form Type8-K
Filing DateJul 27, 2026
Item2.01
CategoryAcquisition/Disposition
CIK0000200406
Accession #jnj-20260727
Risk LevelLOW
SentimentPositive
Signalinformational
Topics
debt financing
What This Means
The company completed a major acquisition or sold off a significant asset. This reshapes the company's portfolio and strategic direction.